P

Praram 9 Hospital PCL
SET:PR9

Watchlist Manager
Praram 9 Hospital PCL
SET:PR9
Watchlist
Price: 25.75 THB 0.98% Market Closed
Market Cap: 20.2B THB
Have any thoughts about
Praram 9 Hospital PCL?
Write Note
Section:
 

Relative Value

The Relative Value of one PR9 stock under the Base Case scenario is 21.2 THB. Compared to the current market price of 25.75 THB, Praram 9 Hospital PCL is Overvalued by 18%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PR9 Relative Value
Base Case
21.2 THB
Overvaluation 18%
Relative Value
Price
P
Worst Case
Base Case
Best Case

Valuation Multiples

4.4
P/S
P/S
Price to Sales
4.4
vs History
0
vs Industry
36
Median 3Y
3.4
Median 5Y
3.1
Industry
2.3
Forward
4.4
More Details
29.2
P/E
P/E
Price to Earnings
29.2
vs History
34
vs Industry
23
Median 3Y
26.8
Median 5Y
27
Industry
23.1
Forward
29.8
More Details
19.9
P/OCF
P/OCF
Price to OCF
19.9
vs History
0
vs Industry
24
Median 3Y
16.3
Median 5Y
16.1
Industry
14.2
More Details
26.1
P/FCFE
P/FCFE
Price to FCFE
26.1
vs History
25
vs Industry
20
Median 3Y
24.6
Median 5Y
21.7
Industry
20.1
More Details
3.8
P/B
P/B
Price to Book Value
3.8
vs History
0
vs Industry
31
Median 3Y
2.9
Median 5Y
2.5
Industry
2.2
More Details
3.9
EV/S
EV/S
Enterprise Value to Sales
3.9
vs History
0
vs Industry
39
Median 3Y
3
Median 5Y
2.7
Industry
2.4
Forward
3.9
More Details
11.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
11.4
vs History
0
vs Industry
25
Median 3Y
9.2
Median 5Y
9
Industry
5
More Details
16.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
16.2
vs History
0
vs Industry
28
Median 3Y
12.9
Median 5Y
12.9
Industry
12.7
Forward
15.8
More Details
22.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
22.3
vs History
28
vs Industry
26
Median 3Y
19.5
Median 5Y
19.8
Industry
17.1
Forward
21.7
More Details
17.7
EV/OCF
EV/OCF
Enterprise Value to OCF
17.7
vs History
0
vs Industry
28
Median 3Y
14.2
Median 5Y
14
Industry
14
More Details
23.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
23.1
vs History
22
vs Industry
21
Median 3Y
21.3
Median 5Y
19.2
Industry
18
More Details
5.3
EV/IC
EV/IC
Enterprise Value to IC
5.3
vs History
0
vs Industry
23
Median 3Y
3.6
Median 5Y
2.8
Industry
1.9
More Details

Multiples Across Competitors

PR9 Competitors Multiples
Praram 9 Hospital PCL Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
TH
Praram 9 Hospital PCL
SET:PR9
20.2B THB 4.4 29.2 16.2 22.3
US
HCA Healthcare Inc
NYSE:HCA
78.1B USD 1.1 13.2 8.3 10.8
SA
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
98B SAR 9.3 44 39 45.3
ZA
Life Healthcare Group Holdings Ltd
JSE:LHC
24.1B Zac 0 0 0 0
ZA
Netcare Ltd
JSE:NTC
20B Zac 0 0 0 0
CN
Aier Eye Hospital Group Co Ltd
SZSE:300015
129.8B CNY 6.3 35.8 27 27
MY
IHH Healthcare Bhd
KLSE:IHH
63.8B MYR 2.8 24.1 13 18.8
IN
Max Healthcare Institute Ltd
NSE:MAXHEALTH
1.1T INR 19.4 105 73 87.1
IN
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
1T INR 5.3 100.7 41.9 57.4
US
Tenet Healthcare Corp
NYSE:THC
12.2B USD 0.6 3.9 5.2 6.5
US
Universal Health Services Inc
NYSE:UHS
11.9B USD 0.8 11.6 7.7 10.7

See Also

Summary
PR9 intrinsic value, competitors valuation, and company profile.
DCF Valuation
PR9 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PR9 stock valuation using valuation multiples.
Wall Street Estimates
PR9 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PR9 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.